{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Gainesville&page=51&state=Florida", "query": { "state": "Florida", "city": "Gainesville", "page": 51 }, "page_size": 10 }, "pagination": { "page": 51, "page_size": 10, "total_count": 5275, "total_pages": 528, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Gainesville&page=52&state=Florida&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Gainesville&page=50&state=Florida&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-04T05:07:09.684Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04503395", "title": "ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aortic Aneurysm, Abdominal" ], "interventions": [ { "name": "ESAR treatment: Endograft + Heli-FX Endoanchor", "type": "DEVICE" }, { "name": "FEVAR treatment : Fenestrated endograft", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "FCRE (Foundation for Cardiovascular Research and Education)", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 204, "start_date": "2021-05-21", "completion_date": "2032-06-01", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-11-04T05:07:09.684Z", "location_count": 9, "location_summary": "La Jolla, California • Stanford, California • Gainesville, Florida + 6 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04503395" }, { "nct_id": "NCT05553964", "title": "SARS-CoV-2 OTC At Home Test", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "COVID-19 Pandemic" ], "interventions": [ { "name": "In Vitro", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "3EO Health", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 64, "start_date": "2022-10-07", "completion_date": "2022-11-18", "has_results": false, "last_update_posted_date": "2022-12-02", "last_synced_at": "2026-11-04T05:07:09.684Z", "location_count": 5, "location_summary": "Gainesville, Florida • Miami, Florida • Sunrise, Florida + 2 more", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Sunrise", "state": "Florida" }, { "city": "Humble", "state": "Texas" }, { "city": "Kingwood", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05553964" }, { "nct_id": "NCT00069511", "title": "12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatitis C" ], "interventions": [ { "name": "UT-231B", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "United Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 72, "start_date": "2003-07", "completion_date": "2004-12", "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-11-04T05:07:09.684Z", "location_count": 6, "location_summary": "Gainesville, Florida • New Orleans, Louisiana • Boston, Massachusetts + 3 more", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00069511" }, { "nct_id": "NCT01710709", "title": "Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar I" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 748, "start_date": "2012-11", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2018-09-21", "last_synced_at": "2026-11-04T05:07:09.684Z", "location_count": 72, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Rogers, Arkansas + 62 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Beverly Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01710709" }, { "nct_id": "NCT07782398", "title": "Momentary Coping Prompts and Hair Steroids in College Students", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Emotional Regulation", "Alcohol Drinking in College", "Emotional Eating", "Aggression" ], "interventions": [ { "name": "Momentary coping prompt", "type": "BEHAVIORAL" }, { "name": "Active control message", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "22 Years", "sex": "ALL", "summary": "18 Years to 22 Years" }, "enrollment_count": 80, "start_date": "2026-09-21", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-11-04T05:07:09.684Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07782398" }, { "nct_id": "NCT04031677", "title": "Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Retroperitoneal Sarcoma", "Liposarcoma", "Leiomyosarcoma" ], "interventions": [ { "name": "Surgery", "type": "PROCEDURE" }, { "name": "Preoperative chemotherapy", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "European Organisation for Research and Treatment of Cancer - EORTC", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2021-01-20", "completion_date": "2028-04-21", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-11-04T05:07:09.684Z", "location_count": 116, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Duarte, California + 92 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04031677" }, { "nct_id": "NCT03407144", "title": "Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hodgkin Lymphoma" ], "interventions": [ { "name": "pembrolizumab", "type": "BIOLOGICAL" }, { "name": "doxorubicin", "type": "DRUG" }, { "name": "vinblastine", "type": "DRUG" }, { "name": "dacarbazine", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "vincristine", "type": "DRUG" }, { "name": "prednisone/prednisolone", "type": "DRUG" }, { "name": "bleomycin", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "Radiotherapy (RT)", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "RADIATION" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "3 Years to 25 Years" }, "enrollment_count": 340, "start_date": "2018-04-09", "completion_date": "2027-02-12", "has_results": false, "last_update_posted_date": "2026-10-02", "last_synced_at": "2026-11-04T05:07:09.684Z", "location_count": 47, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 41 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Downey", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03407144" }, { "nct_id": "NCT01066819", "title": "PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hepatitis C, Chronic" ], "interventions": [ { "name": "Peginterferon alfa-2a [Pegasys]", "type": "DRUG" }, { "name": "Peginterferon alfa-2b [PegIntron®]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1656, "start_date": "2008-01", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2016-08-08", "last_synced_at": "2026-11-04T05:07:09.684Z", "location_count": 105, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Fresno, California + 86 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01066819" }, { "nct_id": "NCT00004228", "title": "Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lymphoma" ], "interventions": [ { "name": "asparaginase", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cytarabine", "type": "DRUG" }, { "name": "daunorubicin hydrochloride", "type": "DRUG" }, { "name": "dexamethasone", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "leucovorin calcium", "type": "DRUG" }, { "name": "mercaptopurine", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" }, { "name": "prednisone", "type": "DRUG" }, { "name": "thioguanine", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "30 Years", "sex": "ALL", "summary": "1 Year to 30 Years" }, "enrollment_count": 393, "start_date": "2000-06", "completion_date": "2015-03-31", "has_results": true, "last_update_posted_date": "2019-08-06", "last_synced_at": "2026-11-04T05:07:09.684Z", "location_count": 152, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 127 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Downey", "state": "California" }, { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00004228" }, { "nct_id": "NCT06063200", "title": "Methylphenidate and Response to Alcohol Cues Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Alcohol Use Disorder", "Attention Deficit Hyperactivity Disorder" ], "interventions": [ { "name": "Methylphenidate Pill", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "18 Years to 25 Years" }, "enrollment_count": 31, "start_date": "2024-03-20", "completion_date": "2025-07-01", "has_results": false, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-11-04T05:07:09.684Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06063200" } ] }